Literature DB >> 11681425

Marked ploidy and BCR-ABL gene amplification in vivo in a patient treated with STI571.

A Sirulink, R T Silver, V Najfeld.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11681425     DOI： 10.1038/sj.leu.2402267

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  6 in total

Review 1.  The second generation of BCR-ABL tyrosine kinase inhibitors.

Authors:  Tetsuzo Tauchi; Kazuma Ohyashiki
Journal:  Int J Hematol       Date:  2006-05       Impact factor: 2.490

2.  Computational analysis of the binding specificity of Gleevec to Abl, c-Kit, Lck, and c-Src tyrosine kinases.

Authors:  Yen-Lin Lin; Benoît Roux
Journal:  J Am Chem Soc       Date:  2013-09-20       Impact factor: 15.419

Review 3.  Imatinib mesylate in combination with other chemotherapeutic agents for chronic myelogenous leukemia.

Authors:  Tetsuzo Tauchi; Kazuma Ohyashiki
Journal:  Int J Hematol       Date:  2004-06       Impact factor: 2.490

4.  Genomic amplification of BCR/ABL1 and a region downstream of ABL1 in chronic myeloid leukaemia: a FISH mapping study of CML patients and cell lines.

Authors:  Anna Virgili; Elisabeth P Nacheva
Journal:  Mol Cytogenet       Date:  2010-09-01       Impact factor: 2.009

5.  Philadelphia chromosome duplication as a ring-shaped chromosome.

Authors:  Cesar Borjas-Gutierrez; Juan Ramon Gonzalez-Garcia
Journal:  Mol Cytogenet       Date:  2016-11-21       Impact factor: 2.009

6.  Masked inv dup(22)(q11.23), tetrasomy 8 and trisomy 19 in a blast crisis-chronic myeloid leukemia after interrupted Imatinib-treatment.

Authors:  Abdulsamad Wafa; Suher Almedani; Thomas Liehr; Walid Al-Achkar
Journal:  Mol Cytogenet       Date:  2015-12-23       Impact factor: 2.009
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.